We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Use of Surface Electromyography Biofeedback to Improve Reaching in Children With Cerebral Palsy

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00473161
First Posted: May 14, 2007
Last Update Posted: May 23, 2014
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Terence Sanger, University of Southern California
  Purpose
A newly-developed device for biofeedback of surface EMG will be used to either increase or decrease activity in the muscles of children with poor reaching due to cerebral palsy.

Condition Intervention Phase
Cerebral Palsy Weakness Hypertonia Device: surface EMG biofeedback Phase 1 Phase 2

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective

Resource links provided by NLM:


Further study details as provided by Terence Sanger, University of Southern California:

Estimated Enrollment: 20
Study Start Date: May 2007
Primary Completion Date: January 2009 (Final data collection date for primary outcome measure)
Detailed Description:
Children ages newborn to 21 with a diagnosis of arm weakness, hypertonia, or hyperkinesia due to cerebral palsy will be recruited. A muscle that is either over-active or under-active will be selected for each child. The child will be provided with the device to wear for 1 month in order to call attention to the identified muscle. At the beginning and end of the month, reaching will be assessed using three-dimensional kinematic motion capture. The outcome measure will be the speed and curvature of reaching to a target in front of the child.
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   1 Month to 21 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Children with movement disorders, cerebral palsy.
Criteria

Inclusion Criteria:

  • weakness, hypertonia, or hyperkinetic disorder affecting one or both arms
  • reduced speed or quality of reaching

Exclusion Criteria:

  • any condition that would increase the risk of participation
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00473161


Locations
United States, California
Stanford University
Stanford, California, United States, 94305
Sponsors and Collaborators
University of Southern California
Investigators
Principal Investigator: Terence D Sanger, MD PhD Stanford University
  More Information

Responsible Party: Terence Sanger, Associate Professor, University of Southern California
ClinicalTrials.gov Identifier: NCT00473161     History of Changes
Other Study ID Numbers: EMG biofeedback
First Submitted: May 11, 2007
First Posted: May 14, 2007
Last Update Posted: May 23, 2014
Last Verified: May 2014

Keywords provided by Terence Sanger, University of Southern California:
movement disorders
childhood

Additional relevant MeSH terms:
Cerebral Palsy
Brain Damage, Chronic
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases


To Top